Other Events ·
At its 2026 Annual Meeting of Shareholders held on June 10, 2026, Orthofix Medical Inc. shareholders approved…
OFIXOrthofix Medical Inc.
At its 2026 Annual Meeting of Shareholders held on June 10, 2026, Orthofix Medical Inc. shareholders approved Amendment No. 5 to the Company's Second Amended and Restated Stock Purchase Plan. This amendment increases the number of common shares available for issuance under the plan by 1,250,000 shares. Additionally, the meeting resulted in the election of eight directors for one-year terms, the approval of an advisory resolution regarding executive compensation, and the ratification of Ernst & Young LLP as the independent auditor for the 2026 fiscal year. Orthofix Medical Inc. is a medical technology company that develops and manufactures products for musculoskeletal and neurovascular care.